Similares a Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy

20 vecinos (text_768) · 233 views · HCPLive · Estados Unidos


★	Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy	HCPLive @hcplivenews	233	Estados Unidos
1	Phase 3 VISIONARY: Sibeprenlimab May Preserve #KidneyFunction in IgA Nephropathy	HCPLive @hcplivenews	981	Estados Unidos	95
5	Nefropatía por IgA en adultos Una revisión actualizada	ENSEÑANDO MEDICINA INTERNA @carloswaldomi	690	—	86
6	SGLT2 EN ERC Beneficio en todos los estadios	ENSEÑANDO MEDICINA INTERNA @carloswaldomi	383	—	85
11	Where Kidney Biopsy Is Heading Next I #IgA Nephropathy Care	HCPLive @hcplivenews	366	Estados Unidos	84
12	Hemodiálisis incremental como forma de inicio del tratamiento sustitutivo renal	Fundación Renal Española @fundacionrenale	275	España	84
2	Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy	HCPLive @hcplivenews	199	Estados Unidos	90
9	Atacicept Approval Brings BAFF/APRIL Targeting to IgAN With Richard Lafayette, MD	HCPLive @hcplivenews	173	Estados Unidos	85
17	FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD	HCPLive @hcplivenews	131	Estados Unidos	84
15	FIND-CKD Trial Poses Finerenone as a "Third Pillar" for Nondiabetic CKD	HCPLive @hcplivenews	123	Estados Unidos	84
10	Tegoprubart Sustains Increased eGFR Longterm Compared to Tacrolimus	HCPLive @hcplivenews	114	Estados Unidos	84
8	Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies	HCPLive @hcplivenews	109	Estados Unidos	85
16	Bimekizumab Data Support Case for Earlier Intervention in HS	HCPLive @hcplivenews	78	Estados Unidos	84
14	Avapritinib's 4-Year Impact on Quality of Life in ISM \| Thanai Pongdee, MD	HCPLive @hcplivenews	73	Estados Unidos	84
4	DUPLEX Trial Results: Key Insights in #FSGS	ReachMD @reachmd	71	Estados Unidos	87
13	Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD	HCPLive @hcplivenews	60	Estados Unidos	84
3	B-Cell–Targeted Therapies Expand in IgA Nephropathy, With Samir Parikh, MD	HCPLive @hcplivenews	27	Estados Unidos	87
20	Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data	HCPLive @hcplivenews	27	Estados Unidos	84
18	Helping Patients with IgAN Navigate Treatment Decisions	ReachMD @reachmd	7	Estados Unidos	84
19	Helping Patients with IgAN Navigate Treatment Decisions	ReachMD @reachmd	2	Estados Unidos	84
7	30032022 - Unidad 3 - Fisiopatología de adultos - Casos de insuficiencia renal	Nancy Monzon @nancymonzon9782	0	—	85